| Unique phenotypes and clonal expansions of human CD4 effector memory T cells re-expressing CD45RA Y Tian, M Babor, J Lane, V Schulten, VS Patil, G Seumois, SL Rosales, ... Nature communications 8 (1), 1473, 2017 | 254 | 2017 |
| Cytomegalovirus: shape-shifting the immune system G Picarda, CA Benedict The Journal of Immunology 200 (12), 3881-3889, 2018 | 142 | 2018 |
| N-glycosylation of mouse TRAIL-R and human TRAIL-R1 enhances TRAIL-induced death F Dufour, T Rattier, S Shirley, G Picarda, AA Constantinescu, A Morlé, ... Cell Death & Differentiation 24 (3), 500-510, 2017 | 93 | 2017 |
| Zoledronic acid as a new adjuvant therapeutic strategy for Ewing's sarcoma patients GA Odri, S Dumoucel, G Picarda, S Battaglia, F Lamoureux, N Corradini, ... Cancer research 70 (19), 7610-7619, 2010 | 88 | 2010 |
| Preclinical evidence that use of TRAIL in Ewing's sarcoma and osteosarcoma therapy inhibits tumor growth, prevents osteolysis, and increases animal survival G Picarda, F Lamoureux, L Geffroy, P Delepine, T Montier, K Laud, ... Clinical Cancer Research 16 (8), 2363-2374, 2010 | 80 | 2010 |
| Glycosaminoglycans as potential regulators of osteoprotegerin therapeutic activity in osteosarcoma F Lamoureux, G Picarda, L Garrigue-Antar, M Baud'huin, V Trichet, ... Cancer research 69 (2), 526-536, 2009 | 60 | 2009 |
| Therapeutic efficacy of soluble receptor activator of nuclear factor-κB-Fc delivered by nonviral gene transfer in a mouse model of osteolytic osteosarcoma F Lamoureux, G Picarda, J Rousseau, C Gourden, S Battaglia, C Charrier, ... Molecular Cancer Therapeutics 7 (10), 3389-3398, 2008 | 51 | 2008 |
| Crystal structure of murine 4-1BB and its interaction with 4-1BBL support a role for galectin-9 in 4-1BB signaling A Bitra, T Doukov, J Wang, G Picarda, CA Benedict, M Croft, DM Zajonc Journal of Biological Chemistry 293 (4), 1317-1329, 2018 | 46 | 2018 |
| Impact of oncopediatric dosing regimen of zoledronic acid on bone growth: preclinical studies and case report of an osteosarcoma pediatric patient S Battaglia, S Dumoucel, J Chesneau, MF Heymann, G Picarda, F Gouin, ... Journal of Bone and Mineral Research 26 (10), 2439-2451, 2011 | 42 | 2011 |
| Regulation of osteoprotegerin pro-or anti-tumoral activity by bone tumor microenvironment F Lamoureux, G Moriceau, G Picarda, J Rousseau, V Trichet, F Rédini Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1805 (1), 17-24, 2010 | 40 | 2010 |
| Advantages of bioluminescence imaging to follow siRNA or chemotherapeutic treatments in osteosarcoma preclinical models J Rousseau, V Escriou, P Perrot, G Picarda, C Charrier, D Scherman, ... Cancer gene therapy 17 (6), 387-397, 2010 | 36 | 2010 |
| TRAIL receptor signaling and therapeutic option in bone tumors: the trap of the bone microenvironment G Picarda, V Trichet, S Téletchéa, D Heymann, F Rédini American journal of cancer research 2 (1), 45, 2012 | 33 | 2012 |
| Interleukin-17D and Nrf2 mediate initial innate immune cell recruitment and restrict MCMV infection R Seelige, R Saddawi-Konefka, NM Adams, G Picarda, JC Sun, ... Scientific reports 8 (1), 13670, 2018 | 29 | 2018 |
| Functional Langerinhigh-Expressing Langerhans-like Cells Can Arise from CD14highCD16− Human Blood Monocytes in Serum-Free Condition G Picarda, C Chéneau, JM Humbert, G Bériou, P Pilet, J Martin, F Duteille, ... The Journal of Immunology 196 (9), 3716-3728, 2016 | 21 | 2016 |
| Loss of connexin43 expression in Ewing's sarcoma cells favors the development of the primary tumor and the associated bone osteolysis J Talbot, R Brion, G Picarda, J Amiaud, J Chesneau, G Bougras, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1832 (4), 553-564, 2013 | 20 | 2013 |
| Structure of human cytomegalovirus UL144, an HVEM orthologue, bound to the B and T cell lymphocyte attenuator A Bitra, I Nemčovičová, G Picarda, T Doukov, J Wang, CA Benedict, ... Journal of Biological Chemistry 294 (27), 10519-10529, 2019 | 18 | 2019 |
| A functional, new short isoform of death receptor 4 in Ewing's sarcoma cell lines may be involved in TRAIL sensitivity/resistance mechanisms G Picarda, S Surget, R Guiho, S Téletchéa, M Berreur, F Tirode, ... Molecular Cancer Research 10 (3), 336-346, 2012 | 16 | 2012 |
| Cytomegalovirus evades TRAIL-mediated innate lymphoid cell 1 defenses G Picarda, R Ghosh, B McDonald, S Verma, N Thiault, R El Morabiti, ... Journal of virology 93 (16), 10.1128/jvi. 00617-19, 2019 | 14 | 2019 |
| Profiling human cytomegalovirus-specific T cell responses reveals novel immunogenic open reading frames R Dhanwani, SK Dhanda, J Pham, GP Williams, J Sidney, A Grifoni, ... Journal of Virology 95 (21), 10.1128/jvi. 00940-21, 2021 | 10 | 2021 |
| Drugs targeting the bone microenvironment: new therapeutic tools in Ewing's sarcoma? F Redini, GA Odri, G Picarda, N Gaspar, MF Heymann, N Corradini, ... Expert Opinion on Emerging Drugs 18 (3), 339-352, 2013 | 10 | 2013 |
